BLYSVIA

Owner

Goods & Services

Transdermal patches for use in the treatment of food allergies; adhesive skin patches for medical use for use in the treatment of food allergies; transdermal and adhesive skin patches for treating, alleviating and preventing the development or progression of allergies and immunological disorders; transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals and medical preparations; patches or epicutaneous systems, namely, patches for cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders; adhesive patches or adhesive epicutaneous systems, namely, patches, for cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders; occlusive patches or occlusive epicutaneous systems, namely, patches, for cutaneous and epicutaneous administration of powdered medical and pharmaceutical substances for treating allergies and immunological disorders; patches or epicutaneous systems, namely, patches, containing a powdered preparation for medical and pharmaceutical use for treating allergies and immunological disorders; patches or epicutaneous systems, namely, patches, for use in the treatment of allergies and immunological disorders; patches or epicutaneous systems, namely, patches, featuring allergens or antigens for treating allergies and immunological disorders; allergy medication; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating food allergies; parts and fittings for the aforesaid goods

Nonmedicated skin patches sold without medication for medical training purposes; nonmedicated skin patches sold without medication for medical use, namely for use in training medical professionals on the transdermal delivery of pharmaceuticals or medical preparations; parts and fittings for all the aforesaid goods